Ambrilia lays off CEO, CFO

Tools

Ambrilia Biopharma is making more cuts to its budget. The Canadian company announced yesterday that it has laid off CEO Philippe Calais, CFO Monique Letourneau, and two other senior managers. Richard La Rue has been appointed Interim CEO. Ambrilia has sold off an early-stage cancer program and halted a Phase III trial as it looks for additional funding to support its operations. Release